GLPwatch
Semaglutide and social media: implications for young women with polycystic ovarian syndrome.
Lancet Child Adolesc Health · 2023
Last updated 2026-07-17| Journal | Lancet Child Adolesc Health, 2023 |
|---|---|
| Citations | 9 |
| Relative citation ratio | 1.35 |
| NIH percentile | 61 |
| Molecules | semaglutide |
| Conditions studied | Pcos |
Full record and abstract on PubMed 36803633 ↗
Related research
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity.
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.